Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Intangibles (2021 - 2025)

Historic Intangibles for Collegium Pharmaceutical (COLL) over the last 5 years, with Q3 2025 value amounting to $725.0 million.

  • Collegium Pharmaceutical's Intangibles fell 2343.41% to $725.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $725.0 million, marking a year-over-year decrease of 2343.41%. This contributed to the annual value of $891.4 million for FY2024, which is 11137.9% up from last year.
  • Collegium Pharmaceutical's Intangibles amounted to $725.0 million in Q3 2025, which was down 2343.41% from $780.5 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Intangibles registered a high of $966.2 million during Q1 2022, and its lowest value of $352.7 million during Q2 2024.
  • Over the past 5 years, Collegium Pharmaceutical's median Intangibles value was $863.7 million (recorded in 2024), while the average stood at $760.1 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Intangibles plummeted by 6292.19% in 2024, and later surged by 12129.55% in 2025.
  • Collegium Pharmaceutical's Intangibles (Quarter) stood at $521.2 million in 2021, then rose by 8.88% to $567.5 million in 2022, then dropped by 25.69% to $421.7 million in 2023, then skyrocketed by 111.38% to $891.4 million in 2024, then dropped by 18.67% to $725.0 million in 2025.
  • Its Intangibles stands at $725.0 million for Q3 2025, versus $780.5 million for Q2 2025 and $835.9 million for Q1 2025.